{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.1","upperLimit":"6.0","value":"3.57"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"224"}],"units":"Participants"}],"description":"Percentage of deaths in induction will be calculated.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients with Down syndrome receive induction chemotherapy","id":"OG000","title":"DS HR B-ALL (Induction)"}],"paramType":"NUMBER","populationDescription":"Patients with DS and HR B-ALL treated with modified Induction","reportingStatus":"POSTED","timeFrame":"At 1 month","title":"Induction Mortality in Patients With DS and HR B-ALL Treated With Modified Induction","type":"SECONDARY","unitOfMeasure":"Percentage of patients"}